Changes in Capillary Carbon Dioxide Partial Pressure (pCO2) While Wearing FFP2 / FFP3 Masks

NCT ID: NCT04980820

Last Updated: 2022-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-19

Study Completion Date

2022-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to determine whether there are any changes in the carbon dioxide partial pressure in medical staff while wearing a filtering face piece (FFP) 2 or FFP3 mask.

Furthermore, changes in the capillary oxygen partial pressure, the subjective respiratory effort and the breathing rate are measured.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the fight against the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), the personal protective equipment (PPE) of medical staff plays a special role. Since the pathogen can be transmitted via droplets, particle-filtering half masks (filtering face piece - FFP) are a substantial part of the PPE. The current data indicate that there may be an increase in the carbon dioxide partial pressure (PcCO2) in the blood when wearing an FFP2 / 3 mask during routine medical activity.

The aim of this prospective cross-over study is to compare the PcCO2 measured by capillary blood sampling from medical staff while wearing an FFP2 or FFP3 mask. The PcCO2 determined without a mask serves as a reference value. While no mask is worn, the PcCO2, the subjective respiratory effort, the breathing rate and the capillary oxygen partial pressure (PcO2) is measured. The study participants then wear an FFP2 or FFP3 mask for one hour, and the same parameters are collected. Subsequently, the participant switches to an FFP3 or FFP2 mask, and the last measurement is conducted after one hour.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypercapnia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

1. arm: starts with no mask - FFP2 mask - FFP3 mask
2. arm: starts with no mask - FFP3 mask - FFP2 mask
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FFP2

This arm starts with a FFP2 mask and switches to a FFP3 mask.

Group Type EXPERIMENTAL

No mask

Intervention Type OTHER

The participant is asked to wear no mask for 10 minutes.

Filtering face mask 2 (FFP2)

Intervention Type DEVICE

The participant is asked to wear a FFP2 mask for 1 hour during work.

Filtering face mask 3 (FFP3)

Intervention Type DEVICE

The participant is asked to wear a FFP3 mask for 1 hour during work.

FFP3

This arm starts with a FFP3 mask and switches to a FFP2 mask.

Group Type EXPERIMENTAL

No mask

Intervention Type OTHER

The participant is asked to wear no mask for 10 minutes.

Filtering face mask 2 (FFP2)

Intervention Type DEVICE

The participant is asked to wear a FFP2 mask for 1 hour during work.

Filtering face mask 3 (FFP3)

Intervention Type DEVICE

The participant is asked to wear a FFP3 mask for 1 hour during work.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No mask

The participant is asked to wear no mask for 10 minutes.

Intervention Type OTHER

Filtering face mask 2 (FFP2)

The participant is asked to wear a FFP2 mask for 1 hour during work.

Intervention Type DEVICE

Filtering face mask 3 (FFP3)

The participant is asked to wear a FFP3 mask for 1 hour during work.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* medical staff working at the Vienna General Hospital
* oral and written consent to take part voluntarily in this trial

Exclusion Criteria

* hypersensitivity / allergy against Nonylvanillamid, Nikotinsäure-beta-butoxyethylester or other component of "Finalgon Salbe"
* not Coronavirus disease-19 vaccinated
* pregnancy
* breastfeeding
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

David M Baron, MD

Assoc. Prof. PD Dr. David Baron, EDIC

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Georg Röder, M.D.

Role: PRINCIPAL_INVESTIGATOR

Medical University of Vienna, Dept. of Anaesthesiology, Critical Care and Pain Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Vienna

Vienna, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

References

Explore related publications, articles, or registry entries linked to this study.

Paules CI, Marston HD, Fauci AS. Coronavirus Infections-More Than Just the Common Cold. JAMA. 2020 Feb 25;323(8):707-708. doi: 10.1001/jama.2020.0757. No abstract available.

Reference Type BACKGROUND
PMID: 31971553 (View on PubMed)

Fletcher SJ, Clark M, Stanley PJ. Carbon dioxide re-breathing with close fitting face respirator masks. Anaesthesia. 2006 Sep;61(9):910. doi: 10.1111/j.1365-2044.2006.04767.x. No abstract available.

Reference Type BACKGROUND
PMID: 16922771 (View on PubMed)

Ozdemir L, Azizoglu M, Yapici D. Respirators used by healthcare workers due to the COVID-19 outbreak increase end-tidal carbon dioxide and fractional inspired carbon dioxide pressure. J Clin Anesth. 2020 Nov;66:109901. doi: 10.1016/j.jclinane.2020.109901. Epub 2020 May 22.

Reference Type BACKGROUND
PMID: 32473501 (View on PubMed)

Kim JH, Benson SM, Roberge RJ. Pulmonary and heart rate responses to wearing N95 filtering facepiece respirators. Am J Infect Control. 2013 Jan;41(1):24-7. doi: 10.1016/j.ajic.2012.02.037. Epub 2012 Sep 1.

Reference Type BACKGROUND
PMID: 22944510 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://www.who.int/publications/i/item/rational-use-of-personal-protective-equipment-for-coronavirus-disease-(covid-19)-and-considerations-during-severe-shortages

Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1144/2021

Identifier Type: -

Identifier Source: org_study_id